{
    "clinical_study": {
        "@rank": "161396", 
        "arm_group": [
            {
                "arm_group_label": "Radial Extracorporeal Shock Wave", 
                "arm_group_type": "Active Comparator", 
                "description": "Radial Extracorporeal Shock Wave applicator"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo applicator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy of treatment of radial shockwave in\n      myofascial pain syndrome in the lumbar region compared to placebo through questionnaires and\n      imaging exams."
        }, 
        "brief_title": "Radial Extracorporeal Shock Wave Treatment (rESWT) of Myofascial Pain Syndrome in Low Back Pain", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Myofascial Pain Syndromes", 
            "Myofascial Trigger Point", 
            "Low Back Pain", 
            "Lumbago"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Back Pain", 
                "Myofascial Pain Syndromes", 
                "Fibromyalgia", 
                "Low Back Pain", 
                "Shock", 
                "Somatoform Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Presenting clinical complaints of lumbar and / or gluteal pains for 3 months or more\n\n          -  Display pain of moderate to severe intensity: visual analogue scale (VAS)> 4\n\n          -  Diagnosis of myofascial pain syndrome in the lumbar and / or gluteal\n\n          -  Authorize in writing the term of free and informed consent to participate in the\n             study\n\n          -  Availability of frequent attendance at hospital\n\n        Exclusion Criteria:\n\n          -  Organic or psychological disorders that contraindication participation of patients in\n             study\n\n          -  Metabolic, infectious, oncological or rheumatologic disorders\n\n          -  Fibromyalgia\n\n          -  Labor dispute\n\n          -  Indication for surgery in column\n\n          -  Contraindications to therapy of shock waves:\n\n               -  Coagulopathy and / or anticoagulant\n\n               -  Pregnancy\n\n               -  Acute infection in soft tissue or bone\n\n               -  Systemic Infections\n\n               -  Presence of ulcers at treatment sites\n\n               -  Presence of larger vessels or nerves at treatment sites\n\n               -  Polyneuropathies\n\n               -  Malignancies\n\n               -  Cardiac arrhythmias or use of pacemaker\n\n               -  Epilepsy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01835795", 
            "org_study_id": "CAAE 06251612.7.0000.0068"
        }, 
        "intervention": [
            {
                "arm_group_label": "Radial Extracorporeal Shock Wave", 
                "description": "Radial Extracorporeal Shock Wave applicator use in 6 sessions with 1 week of interval, 1000 impulses per myofascial trigger point, 10 to 15 hertz frequency, 2 to 4 bar pressure", 
                "intervention_name": "Radial Extracorporeal Shock Wave", 
                "intervention_type": "Device", 
                "other_name": "Swiss DolorClast\u00ae CLASSIC applicator"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo applicator, use in 6 sessions with 1 week of interval, 1000 impulses per myofascial trigger point, 10 to 15 hertz frequency, 2 to 4 bar pressure", 
                "intervention_name": "Placebo", 
                "intervention_type": "Device", 
                "other_name": "Swiss DolorClast\u00ae CLASSIC placebo applicator"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Myofascial Pain Syndromes", 
            "Myofascial Trigger Point", 
            "Low Back Pain", 
            "Lumbago", 
            "Shock Waves, High-Energy", 
            "High-Energy Shock Waves", 
            "Interdisciplinary Health Team", 
            "Multidisciplinary Pain Centers"
        ], 
        "lastchanged_date": "April 18, 2013", 
        "location": {
            "contact": {
                "email": "koba@globo.com", 
                "last_name": "Ricardo Kobayashi"
            }, 
            "facility": {
                "address": {
                    "city": "Sao Paulo", 
                    "country": "Brazil", 
                    "zip": "05403-010"
                }, 
                "name": "IOT HCFMUSP - Instituto de Ortopedia e Traumatologia do Hospital das Cl\u00ednicas da Faculdade de Medicina da USP"
            }, 
            "investigator": {
                "last_name": "Ricardo Kobayashi", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective, Comparative, Randomized Study of the Effectiveness of Shock Wave Treatment in Myofascial Pain Syndrome in Low Back Pain", 
        "overall_official": {
            "affiliation": "IOT HCFMUSP - Instituto de Ortopedia e Traumatologia do Hospital das Cl\u00ednicas da Faculdade de Medicina da USP", 
            "last_name": "Ricardo Kobayashi", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The outcome will be assessed by Visual Analogue Scale (VAS)", 
            "measure": "Evidence of pain relief by visual analogue scale (VAS) of radial extracorporeal shock waves in myofascial pain syndrome in the lumbar and gluteal region compared to placebo", 
            "safety_issue": "Yes", 
            "time_frame": "6 weeks after the last session of shockwave results will be measured"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01835795"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Sao Paulo", 
            "investigator_full_name": "Ricardo Kobayashi", 
            "investigator_title": "Researcher and Collaborator of Pain Group", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Sao Paulo", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Sao Paulo", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}